PBTC-039 – Summary for Patients and Families Title: PBTC-039, Phase II study of Peginterferon alfa-2b (PEGIntron) for pediatric patients with unresectable or recurrent craniopharyngioma This is a brief summary of a cli - Peginterferon alfa-2b - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-12-23 10:31:23 Radiation therapy Radioactivity Radiobiology Methadone Craniopharyngioma Breast cancer treatment Atypical teratoid rhabdoid tumor Medicine Brain tumor Radiation oncology		PBTC-039 – Summary for Patients and Families Title: PBTC-039, Phase II study of Peginterferon alfa-2b (PEGIntron) for pediatric patients with unresectable or recurrent craniopharyngioma This is a brief summary of a cli Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 139,98 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.